-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0599-131115.pdf
June 20, 2013 - acknowledges
uncertainty regarding the comparative effectiveness related to outcomes such as
mortality and disease … Elderly, disabled or homebound adults living in the community who
require primary care for a chronic disease … disability
Intervention(s): Home-based primary care programs utilizing in-home visits for chronic
disease … nursing home admissions, Health care
utilization (e.g., ER visits, hospital admissions), cost, relevant disease-specific
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
September 27, 2012 - Hepatic metastasis from colorectal cancer is defined as resectable when it is anticipated that
disease … The volume of disease in these patients is small, either in terms
of lesion size or number of lesions … Patients whose treatment has failed or whose disease progressed while receiving systemic
chemotherapy … These patients generally have large–volume, diffuse disease and are not
candidates for ablation but … Intermediate outcomes
that impact overall survival include time to progression of disease and tumor
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-applicability_methods.pdf
July 01, 2012 - Spectrum of disease in
practice and in studies.
Source of
population not
described. … Exclude if no disease
outcomes and
outcomes key to
understanding
intended use case. … Spectrum Effect
The severity or type of disease may effect the accuracy of the test. … or fetal anatomic survey, and MRI for detection of spinal conditions or joint disease. … Prevalence is inexorably tied to disease definitions that may also change over time.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
May 01, 2013 - to
differentiate between patients with BCLC stage A and
B liver disease across publications. … This was calculated from the date of
disease response to treatment to the date of disease progression … Subgroups
of interest include age, sex, HCC stage, disease etiology,
lesion size, and multifocal disease … • No studies presented subgroup analyses on age, sex,
disease etiology, or HCC stage. … RFA to PEI/PAI: disease etiology Insufficient None of the 3 RCTs reported subgroup analysis by disease
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
December 15, 2010 - Ischemic heart disease CVD surgery and procedures
Arrhythmias Quality of life
Other heart disease … o Congestive heart failure
o Valvular disease
• Cerebrovascular disease
o All stroke
o Hemorrhagic … Use of complementary therapies in patients with cardiovascular
disease. … Use of herbal products and potential interactions in patients with
cardiovascular diseases. … Herbal medicine for the treatment of cardiovascular disease:
clinical considerations.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - CER # 28:
Disease-Modifying Antirheumatic Drugs (DMARDs) in
Children with Juvenile Idiopathic Arthritis … Lancet, and the New England Journal of
Medicine) and five specialty journals (Annals of the Rheumatic Diseases … The ACR
Pediatric 30 is also a relative measure of
disease activity and not a measure of current
disease … Of Internal Medicine
BMJ
JAMA
Lancet
New England Journal Of Medicine
Annals of the Rheumatic Diseases … The ACR
Pediatric 30 is also a relative measure of
disease activity and not a measure of current
disease
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - CER # 28:
Disease-Modifying Antirheumatic Drugs (DMARDs) in
Children with Juvenile Idiopathic Arthritis … Lancet, and the New England Journal of
Medicine) and five specialty journals (Annals of the Rheumatic Diseases … The ACR
Pediatric 30 is also a relative measure of
disease activity and not a measure of current
disease … Of Internal Medicine
BMJ
JAMA
Lancet
New England Journal Of Medicine
Annals of the Rheumatic Diseases … The ACR
Pediatric 30 is also a relative measure of
disease activity and not a measure of current
disease
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
December 01, 2013 - in this field focuses on drugs and biologics for irritable bowel syndrome and inflammatory bowel
diseases … Bethesda (MD): National
Digestive Diseases Information
Clearinghouse (NDDIC); 2007 May [updated … National Digestive Diseases Information
Clearinghouse (NDDIC). Short bowel syndrome. … Bethesda (MD): National Institute of
Diabetes and Digestive and Kidney Diseases
(NIDDK), National … Teduglutide, a glucagon-like peptide-
2 analog for the treatment of gastrointestinal
diseases, including
-
effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
October 01, 2007 - medical service from a provider with a diagnosis
coded according to International Classification of Diseases … in the past year
0.96 0.54 �0.01 0.74 0.83 0.12
Mean no. cardiovascular disease-related
diagnoses … 0.25 0.17 �0.01 0.21 0.23 0.21
Mean no. cardiovascular disease-related
hospitalizations in the past … Prevention of coronary heart disease with
pravastatin in men with hypercholesterolemia. … The Long-Term Intervention with Pravastatin in Ischaemic Disease
(LIPID) Study Group.
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 13: Pulmonary Disease … Slowing disease progression could lead to improved quality of life and reduced
costs. … None of these approaches halts disease progression. … exacerbations, which may slow disease progression. … Slowed disease progression could
lead to improved patient quality of life and reduced costs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
December 01, 2011 - Incidence of metastatic disease
d. Quality of life
e. Costs
5. … No more than 20 percent of the
study sample could exhibit more advanced disease. … We also extracted
definitions of disease progression. … additional basic and clinical research is
needed to more accurately classify or predict those men
whose diseases … No trial provided results from comparisons of AS with RP
or RT in men with localized diseases.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
June 01, 2012 - Spectrum effect
The severity or type of disease may affect test accuracy. … Secular trends in population risk and disease prevalence
Prevalence is tied to disease definitions that … A simple change in definition can have a great impact on disease prevalence. … be diagnosed and have the course of their disease altered. … Has the treatment of the related disease improved or changed?
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
June 01, 2012 - Spectrum effect
The severity or type of disease may affect test accuracy. … Secular trends in population risk and disease prevalence
Prevalence is tied to disease definitions that … A simple change in definition can have a great impact on disease prevalence. … be diagnosed and have the course of their disease altered. … Has the treatment of the related disease improved or changed?
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
January 01, 2012 - Horizon Scanning System – Potential High
Impact Interventions Report
Priority Area 13: Pulmonary Disease … ES-2
Pulmonary Disease, Including Asthma, Interventions ........................................... … Priority Area 13: Pulmonary Disease, Including Asthma
Topic High Impact Potential
1. … Roflumilast (Daliresp) for treatment of chronic obstructive pulmonary disease No high-impact potential … The primary treatment goal is
to lessen symptoms and slow disease progression.
-
effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
October 01, 2007 - In addition, patients with more severe disease are assumed to
have lower survival odds regardless of … severity,
this leads to the following surgery choice model as a function
of disease severity:
S � c0 … If the survival risk of BCSI is thought to increase
with L (b1 � 0), the patients with higher disease … and disease severity in-
creases (eg, larger vs. smaller tumor size) as we move to the
right on the … In this case,
ESBC patients with the lowest disease severity and those with
the highest disease severity
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - England Journal of Medicine), as well as these specialty journals: Rheumatology,
Annals of Rheumatic Diseases … oral
DMARD:
Mixed results for disease activity. … Legend: ACR: American College of Rheumatology; DAS: Disease Activity Score; DMARD: Disease-modifying … factor-alpha antagonists
and the risk of hospitalization for infection in patients with autoimmune diseases … MEDICINE
BMJ
JAMA
LANCET
NEW ENGLAND JOURNAL OF MEDICINE
ANNALS OF THE RHEUMATIC DISEASES
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - England Journal of Medicine), as well as these specialty journals: Rheumatology,
Annals of Rheumatic Diseases … oral
DMARD:
Mixed results for disease activity. … Legend: ACR: American College of Rheumatology; DAS: Disease Activity Score; DMARD: Disease-modifying … factor-alpha antagonists
and the risk of hospitalization for infection in patients with autoimmune diseases … MEDICINE
BMJ
JAMA
LANCET
NEW ENGLAND JOURNAL OF MEDICINE
ANNALS OF THE RHEUMATIC DISEASES
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
January 01, 2007 - Peripheral vascular disease. … morbidity, microvascular
disease, and peripheral vascular disease. … lactic acidosis would help
determine the safety of using this medication in
populations with comorbid diseases … , congestive heart failure,
liver disease, or psychiatric disease. … medications in effects on peripheral vascular disease.
2e.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_executive.pdf
January 01, 2013 - Disease-Specific Health Outcomes
The effect of CM on disease-specific outcomes was
inconsistent. … Older adults
with one or more
chronic diseases
Mortality. … Older adults
with one or more
chronic diseases
Disease burden. … Older adults
with one or more
chronic diseases
Personal contact. … A taxonomy for disease
management: a scientific statement from the American Heart
Association Disease
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-outcomes_methods.pdf
July 01, 2012 - screening for reportable diseases
such as syphilis or HIV. … Numerous clinical management effects might follow testing for
coronary artery disease with CT. … An individual diagnosed with coronary disease might alter his or her lifestyle to
reduce disease progression … Although the prognoses for some diseases are minimally modifiable with current
treatments, most prognostic … Principles and
practice of mass screening for disease. WHO
Chronicle 1968;22:473.
8.